Intracellular Therapies is developing novel drugs for CNS disorders

Description: Intracellular Therapies, Inc. (ITI) is developing novel drugs for the treatment of depression, schizophrenia, Parkinson1s and Alzheimer1s disease and other Central Nervous System (CNS) disorders, based on proprietary targets identified and validated in vivo.

Keywords: Intracellular Therapies, Inc. (ITI), Intracellular Therapies, Inc. (ITI), novel drugs, depression, schizophrenia, Parkinson1s disease, Alzheimer1s disease, Central Nervous System (CNS) disorders,

Intracellulartherapies.com has 1 URLs listed in 2 Dmoz categories.

Intra-Cellular Therapies, Inc.
Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts for headquarters in New York City.
http://www.intracellulartherapies.com/
Top/Business/Biotechnology_and_Pharmaceuticals/Pharmaceuticals/Biopharmaceuticals/Research_and_Development

Intra-Cellular Therapies, Inc.
Developing novel drugs against targets inside nerve cells to treat depression, schizophrenia, Parkinson's and Alzheimer's disease. Includes therapeutic projects, target biochemistry, corporate data and contacts.
http://www.intracellulartherapies.com/
Top/Regional/North_America/United_States/New_York/Localities/N/New_York_City/Manhattan/Business_and_Economy/Industrial